Nanocell Therapeutics’ Post

📢 NanoCell Therapeutics Announces Animal Proof of Concept Data Demonstrating Non-viral DNA Delivery for In Vivo CAR-T Cell Generation Presented today at SITC and earlier at ESGCT, NanoCell Therapeutics’ non-viral, targeted lipid nanoparticle (tLNP) technology shows promising potential for generating long-lasting CAR-T cells directly in vivo. 🧬 This approach demonstrated successful T-cell targeting and activation, generating functional CAR-T cells that control tumors and extend survival in preclinical models. 🧫✨ For further details, check out the full release here:  https://lnkd.in/d8K3MHXF #NanoCellTx #GeneTherapy #CART #SITC2024 #ESGCT2024 #CellTherapy